Medical device and MedTech insights, news, tips and more

ChoiceSpine® Announces Standalone Indication for Blackhawk® Ti 3D Printed Cervical Spacer System

September 21, 2023


ChoiceSpine LLC, a privately held spinal device company held by Altus Capital Partners in Knoxville, TN, is pleased to announce today that it has received clearance from the U.S. Food and Drug Administration (FDA) to market the Blackhawk® Ti 3D Printed Cervical Spacer System with standalone clearance. Blackhawk® Ti utilizes preassembled integrated anchor technology with a proven cam-locking mechanism. Featuring BioBond® 3D Printed Titanium porous structure, Blackhawk® Ti is available in two anatomical footprints with significant room for graft material and large lateral windows for enhanced visual confirmation.

The expanded indication of the Blackhawk® Ti Standalone Cervical Spacer System to a preexisting lineup of world-class ChoiceSpine solutions comes with great industry enthusiasm. Recognized for providing excellent products to improve people’s lives through a positive customer experience, the company promotes product features unique to the industry. ChoiceSpine is eager to release the Blackhawk® Ti Standalone Cervical Spacer System with expanded indications into the market.

“The Blackhawk® Ti Standalone Cervical Spacer System provides excellent intra and post-operative results for my patients requiring the anterior cervical approach,” said Dr. Anders Cohen, DO, Lead Design Surgeon. “The wide variety of implant footprints and profiles allows for restoration of disc height and optimal sagittal balancing. Furthermore, what sets the Blackhawk® Ti apart from others is the simplicity of the implant design with its integrated bone anchors and instrumentation that help reduce surgery time by decreasing the number of steps in the procedure.”

“The expanded indication of the Blackhawk® Ti Standalone Cervical Spacer System is the natural progression for the product platform,” states Steve Ainsworth, PhD, ChoiceSpine’s Executive Vice President of Strategy and Technology. “Blackhawk® Ti is the first to market a 3D printed system that utilizes preassembled integrated anchor technology. Blackhawk® Ti is just one of ChoiceSpine’s numerous 3D printed titanium fusion solutions. This standalone clearance is an excellent example of how ChoiceSpine brings technically superior spinal devices to the market and does Spine the Right Way℠.”

The Blackhawk® Ti Standalone Cervical Spacer System includes:

  • ChoiceSpine’s proprietary 3D printed BioBond® technology
  • Preassembled integrated anchor technology
  • Large open space for bone graft containment & maximum visualization
  • 6° lordotic and convex profile configurations available
  • Simultaneous, single-step anchor deployment
  • External locking indication for easy confirmation

ChoiceSpine offers a variety of surgeon-focused product lines designed to be safe, efficient, and easy to use. By focusing on a collaborative team approach with physicians and industry partners, ChoiceSpine continues to deliver upon product commitments, maintain cutting-edge research and development, and bring technically superior products to the forefront of the spinal implant industry. For more information, please visit

Altus Capital Partners is a private equity firm that controls investments in middle-market manufacturing businesses. Our exclusive focus on manufacturing gives us a unique understanding of the opportunities and challenges companies face in the sector. We utilize a patient, thoughtful investment approach and seek to partner with the management teams of our operating companies to achieve growth. For more information, please visit

See Full Press Release at the Source: ChoiceSpine® Announces Standalone Indication for Blackhawk® Ti 3D Printed Cervical Spacer System

Press Release by: ChoiceSpine

Legacy MedSearch has more than 35 years of combined experience recruiting in the medical device industry. We pride ourselves on our professionalism and ability to communicate quickly and honestly with all parties in the hiring process. Our clients include both blue-chip companies and innovative startups within the MedTech space. Over the past 17 years, we have built one of the strongest networks of device professionals ranging from sales, marketing, research & , quality & regulatory, project management, field service, and clinical affairs.

We offer a variety of different solutions for hiring managers depending on the scope and scale of each individual search. We craft a personalized solution for each client and position with a focus on attracting the best possible talent in the shortest possible time frame.

Are you hiring?
Contact us to discuss partnering with Legacy MedSearch on your position.

More insights

March 7, 2024
FDA Clears Dexcom’s First Over-the-Counter Continuous Glucose Monitor
Learn More
March 1, 2024
FDA greenlights Boston Scientific’s Novel Drug-Coated Balloon for Coronary In-Stent Restenosis
Learn More
February 21, 2024
Sparrow BioAcoustics Launches Software That Turns a Smartphone into a Stethoscope 
Learn More

Begin your legacy now. We are your medtech and medical device talent advisory firm.